Bitcoin ETFs Shed $100M: Analysts Anticipate Significant Support Disruption
Amidst $101M Outflows, Bitcoin ETFs Grapple with Potential Dip Below Crucial $108,000 Support Level
Key Points
- US spot Bitcoin ETFs saw net outflows of $101 million on October 22, while BlackRock’s iShares Bitcoin Trust registered an inflow of $73.6 million.
- Ethereum ETFs also experienced a net outflow of $18.7 million.
On October 22, exchange-traded funds (ETFs) for US spot Bitcoin (BTC) recorded a net outflow of $101 million.
In contrast, BlackRock’s iShares Bitcoin Trust (IBIT) saw an inflow of $73.6 million.
Trend Mirrored in Ethereum ETFs
Ethereum (ETH) ETFs showed a similar trend, with a total net outflow of $18.7 million, based on data from SoSoValue.
Analysts suggest that this decline is due to ongoing macroeconomic uncertainty and reduced confidence in risk assets. This follows US President Donald Trump’s tariff announcement earlier in October and the US government shutdown.
Bitcoin’s Critical Support Under Pressure
Bitcoin is currently trading around $110,000, having failed to reclaim the $113,000 level earlier in the week. Analysts from Bitfinex caution that the $107,000–$108,000 range has become increasingly fragile. They note that institutional buyers have been largely absent during the pullback.
From October 13 to 17, spot Bitcoin ETFs saw outflows exceeding $1.23 billion, a clear sign of fading demand. According to CryptoQuant, the 3–6 month UTXO realized price level, currently around $108,300, is acting as a key mid-term support.
This indicates that Bitcoin is testing the average cost basis of holders who accumulated during the last rally. A decisive break below this level could trigger further downside.
Market Data Indicates Demand Exhaustion
Data from Glassnode shows that Bitcoin now trades below both the short-term holders’ cost basis ($113,100) and the 0.85 quantile ($108,600). These levels have historically marked a transition into mid-term bearish phases.
Long-term holders have increased distribution, with daily spending exceeding 22,000 BTC. This indicates sustained profit-taking pressure.
Options data also shows rising demand for put contracts as traders hedge against further declines. Implied volatility has surged, while open interest remains near all-time highs. This indicates growing nervousness among market participants.
Analysts note that short-term rallies are being met with defensive positioning rather than optimism, suggesting that recovery momentum may take time to rebuild.
If institutional inflows do not rebound in the coming weeks, analysts warn that the market could enter a prolonged consolidation phase below $110,000. However, a sustained defense of the $108,000 zone, backed by renewed ETF demand, could stabilize price action and set the stage for recovery heading into November.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
